Search Results - "Morreau, Johannes"
-
1
Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma
Published in Oncotarget (22-08-2017)“…Discrimination of pancreatic ductal adenocarcinoma (PDAC) from chronic pancreatitis (CP) or peritumoral inflammation is challenging, both at preoperative…”
Get full text
Journal Article -
2
Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non‐medullary thyroid cancer
Published in Cellular oncology (Dordrecht) (01-06-2021)“…Purpose Non-medullary thyroid cancer (NMTC) treatment is based on the ability of thyroid follicular cells to accumulate radioactive iodide (RAI). However, in a…”
Get full text
Journal Article -
3
De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry
Published in The Journal of pathology (01-01-2015)“…An essential and so far unresolved factor influencing the evolution of cancer and the clinical management of patients is intratumour clonal and phenotypic…”
Get full text
Journal Article -
4
Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study
Published in British journal of surgery (14-10-2022)“…The recently identified classical and basal-like molecular subtypes of pancreatic cancer impact on overall survival (OS). However, the added value of routine…”
Get full text
Journal Article -
5
[18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules
Published in Molecular imaging and biology (01-06-2023)“…Purpose The current study explored the association between 2-[ 18 F]fluoro-2-deoxy-D-glucose ([ 18 F]FDG) uptake and the quantitative expression of…”
Get full text
Journal Article -
6
Expression of HIF-1α in medullary thyroid cancer identifies a subgroup with poor prognosis
Published in Oncotarget (25-04-2017)“…Medullary thyroid cancer (MTC) comprises only 4% of all thyroid cancers and originates from the parafollicular C-cells. HIF-1α expression has been implied as…”
Get full text
Journal Article